Dose-dependent influence of two-week administration of simvastatin and metoprolol injection on the blood pressure in normocholesterolemic rats

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 1, 2008, Pages 147-151

  Owczarek, Jacek ^a   Jasińska, Magdalena ^a   Orszulak Michalak, Daria ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Blood pressure; Metoprolol; Rats; Simvastatin

Indexed keywords

METHYLCELLULOSE; METOPROLOL; SIMVASTATIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; MALE; NONHUMAN; RAT; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INJECTIONS, INTRAPERITONEAL; MALE; METHYLCELLULOSE; METOPROLOL; RATS; RATS, WISTAR; SIMVASTATIN;

EID: 42549121086     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chen Z.M., Pan H.C., Chen Y.P., Peto R., Collins R., Jiang L.X., Xie J.X., Liu L.S.: Lancet 366, 9497 (2005).
2. Maron D.J., Fazio S., Linton M.F.: Circulation 101, 207 (2000).
3. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study group: prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N. Engl. J. Med. 339, 1349 (1998).
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 8939 (1994).
5. Sacks F.M., Pfeffer M.A., Moye L.A., et al.: N. Engl. J. Med. 335, 1001 (1996).
6. Fonarow G.C., Wright R.S., Spencer F.A., et al.: Am. J. Cardiol. 96, 611 (2005).
7. Chen Z., Peto R., Collins R., MacMahon S., Lu J., Li W.: Br. Med. J. 303, 273 (1991).
8. Njølstad I., Arnesen E., Lund-Larsen PG.: Circulation 93, 450 (1996).
9. Jones S.P., Trocha S.D., Lefer D.J.: Arterioscler. Thromb. Vasc. Biol. 21, 2059 (2001).
10. Kaneider N.C., Reinisch C.M., Dunzendorfer S., Meierhofer C., Djanani A., Wiedermann C.J.: Atherosclerosis158, 23 (2001).
11. Laufs U., Gertz K., Dirnagl U., Bohm M., Nickenig G., Endres M.: Brain Res. 28, 23 (2002).
12. Lefer A.M., Campbell B., Shin Y.K., Scalia R., Hayward R., Lefer D.J.: Circulation 100, 178 (1999).
13. Lefer D.J., Jones S.P., Girod W.G., et al.: Am. J. Physiol. Heart Circ. Physiol. 276, H1943 (1999).
14. Cefle K., Tamer S., Kaymaz A.A., et al.: Clin. Hemorheol. Microcirc. 26, 265 (2002).
15. Sever P.S.: Am. J. Med. 118 Suppl. 12A, 3 (2005).
16. Wierzbicki A.S., Poston R., Ferro A.: Pharmacol. Ther. 99, 95 (2003).
17. Mühlhäuser U., Zolk O., Rau T., Münzel F., Wieland T., Eschenhagen T.: FASEB J., express article 10.1096/fj.05-5067fje. Published online February 8, 2006.
18. Muntz K.H., Sternweis P.C., Gilman A.G., Mumby S.M.: Mol. Biol. Cell 3, 49 (1992).
19. Simonds W.F., Butrynski J.E., Gautam N., Unson C.G., Spiegel A.M.: J. Biol. Chem. 266, 5363 (1991).
20. Murga C., Esteban N., Ruiz-Gomez A., Mayor F.Jr.: FEBS Lett. 409 24 (1997).
21. Rikitake Y., Liao K.: Circ. Res. 97, 1232 (2005).
22. Seachrist J.L., Anborgh P.H., Ferguson S.G.: J. Biol. Chem. 275, 27221 (2000).
23. Golomb B.A., Ritchie J.B., Criqui M.H., Dimsdale J.E.: Circulation; 110, Suppl III, 402 (2004).
24. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G. et al.: N. Engl. J. Med. 335, 1001 (1996).
25. Poulter N., Sever P.S.: Circulation 110, Suppl. III (2004).
26. Wierzbicki A.S.: J. Hum. Hyperten. 20 554 (2006).